Aetna Inc. (NYSE:AET) Given Buy Rating At Barclays

Aetna Inc. (NYSE:AET) Given Buy Rating At Barclays


In a research note to investors, Barclays Reiterated Rating on Aetna Inc. (NYSE:AET) with a Buy and no price target.

Shares of Aetna Inc. (NYSE:AET) are trading -1.269% at the time of writing on the news and in the range of 113.620 – 115.930 for the current session. In taking a deeper look at the stock and where it might be headed, brokerage firms on Wall Street currently have a consensus one year price target of 139.070 on the shares. This is according to analysts surveyed by Thomson Reuters First Call. The sell-side analysts are projecting earnings per share of 1.820 for the next fiscal quarter. For the current year, analysts are predicting earnings of 7.410 per share according to First Call.

In looking at where the stock is trading on a technical level, the stock is trading -5.565% away from its 50 day moving average of 120.577. Based on the most recent available data, the equity is -15.278% off of its 52-week high of 134.400 and +58.567% away from its 52-week low which is 71.810.

In taking a look at the company’s valuation, the firm’s price to earnings ratio stands at 18.843. This is a crucial indicator investors watch as higher ratios compared to peers, would suggest higher future earnings growth potential for the stock. The price to current year EPS estimates from research analysts currently stands at 15.346. In looking further ahead, potential investors should note that the company’s price to next year’s EPS estimates is 13.903.

Today, the stock opened at 114.880 and the last bid at the time of writing stood at 113.867. During the session thus far, the equity dipped down to 113.620 and touched 115.930 as the high point. Aetna Inc. Common Stock has a market cap of 39.76B and has seen an average daily volume of 2891110 over the past three months.